Ulcerative colitis and coexisting colorectal cancer: recurrence rate after restorative proctocolectomy

Ann Surg Oncol. 1994 Nov;1(6):512-5. doi: 10.1007/BF02303617.

Abstract

Background: The association between mucosal ulcerative colitis (MUC) and adenocarcinoma is well established.

Methods: Records of patients who had undergone restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) from 1983 through 1992 were examined. Of these, 604 had MUC and 27 (4.3%) had MUC with coexisting cancer. Patients were surveyed annually for recurrent disease. Pouch function and quality of life were evaluated with a questionnaire and physical examination.

Results: The duration of disease was longer (p = 0.001) in patients with cancer (16.1 +/- 8.0 years) than in those without cancer (9.1 +/- 7.1 years), although the mean age at diagnosis of MUC was the same. Of the 27 patients, 20 had colon cancer and seven had rectal cancer. Multicentricity was found in seven (25.9%) patients. Using the TNM staging classification, 14 patients (51.8%) had stage 1 cancer, eight (29.6%) had stage 2, four (14.8%) had stage 3, and one (3.8%) had stage 4. The patient with stage 4 cancer died 5 months after surgery and was excluded from the follow-up analysis. During a mean follow-up time of 4.3 +/- 2.6 years, cancer recurred in two of the remaining 26 patients (7.7%). In one patient, a local recurrence was found 8 months after surgery, and distant metastases were found in the other patient 35 months after surgery. Both recurrences were in patients with colon cancer. Two of the 26 patients died; one death was related to cancer recurrence (3.8%). Pouch function is good to excellent in all surviving patients.

Conclusions: Restorative proctocolectomy for patients with MUC and coexisting colorectal cancer can be performed with a favorable prognosis and function. It is appropriate for curative intent, given that an adequate margin without tumor is obtained.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Anal Canal / surgery*
  • Anastomosis, Surgical
  • Chemotherapy, Adjuvant
  • Colitis, Ulcerative / complications
  • Colitis, Ulcerative / mortality
  • Colitis, Ulcerative / surgery*
  • Colonic Neoplasms / complications
  • Colonic Neoplasms / drug therapy
  • Colonic Neoplasms / mortality
  • Colonic Neoplasms / secondary
  • Colonic Neoplasms / surgery*
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Ileum / surgery*
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local / epidemiology*
  • Neoplasm Staging
  • Proctocolectomy, Restorative*
  • Rectal Neoplasms / complications
  • Rectal Neoplasms / drug therapy
  • Rectal Neoplasms / mortality
  • Rectal Neoplasms / pathology
  • Rectal Neoplasms / surgery*
  • Survival Rate